There is now a large body of experimental evidence showing that MMR contributes to the AO and disease progression in HD by promoting somatic expansion of the pathogenic CAG repeat, highlighting the MMR pathway as a potential target for therapeutic interventions14. The gene discussed is MRC1; the disease is Huntington disease.